To find and enroll in a Retatrutide trial, you must navigate the official channels used by Eli Lilly (the manufacturer) and global health regulators. Most of these trials fall under the TRIUMPH program, which specifically studies Retatrutide for obesity, obstructive sleep apnea, and knee osteoarthritis.
Disclaimer: The content on this website is for educational and aesthetic discussion purposes only. Clinical trials involve the use of experimental drugs with potential unknown side effects. Always consult with a licensed physician and read all informed consent documents thoroughly.
1. Where to Find Active Trials
The most reliable source for clinical trials is the global database maintained by the National Institutes of Health (NIH).
- ClinicalTrials.gov: This is the primary database. Search for “Retatrutide” or the developmental code “LY3437943.”
- Eli Lilly Trial Guide: The manufacturer has a dedicated portal (Lilly Trials) where you can search by your zip code to find nearby research sites.
- Local Research Centers: Many large universities and private medical research groups host these trials. Searching for “Clinical Research [Your City]” can often yield direct contact info for coordinators.
2. Eligibility Criteria: Who Can Join?
Clinical trials are looking for specific “phenotypes” to ensure the data is clean. For the TRIUMPH-1 and similar obesity trials, the requirements are typically:
- BMI Requirements: Usually a BMI of 30, or 27 with at least one weight-related complication (e.g., high blood pressure or high cholesterol).
- Age: Adults 18 years or older.
- Health History: You generally must be free of type 1 or type 2 diabetes (for the obesity-specific trials) and have no history of pancreatitis or certain thyroid cancers.
- The “Washout” Period: You cannot have used other GLP-1 drugs (like Ozempic/Wegovy or Mounjaro/Zepbound) within a certain timeframe (usually 3–6 months) before the trial begins.
3. The Enrollment Process
If you find a trial that is “Recruiting,” follow these steps:
- Prescreening: You will answer a series of questions online or over the phone regarding your weight, medical history, and current medications.
- The Screening Visit: If you pass prescreening, you will go to the clinic for blood work, an EKG, and a physical exam to ensure you meet the strict safety metrics.
- Randomization: This is the “Hardmaxxer’s” gamble. Retatrutide trials are double-blind and placebo-controlled. You have a $25\%$–$50\%$ chance (depending on the trial design) of being placed in the placebo group, where you receive a saline injection instead of the drug.
4. Retatrutide Trial Phases (2024–2026)
| Phase | Focus | Status |
| Phase 1 | Safety & Dosage | Completed |
| Phase 2 | Efficacy & Side Effects | Completed (Showed up to $24\%$ weight loss) |
| Phase 3 | Large Scale / Comparison | Active / Recruiting (TRIUMPH Trials) |
| FDA Approval | Market Release | Anticipated late 2025 or 2026 |
5. Risks vs. Aesthetic Reward
For someone focused on [Skull Architecture] and facial leanness, the reward is the potentially unprecedented fat loss that reveals the jawline. However, consider the risks:
- Placebo Risk: You may spend months attending appointments only to receive a placebo.
- The “Blind” Factor: If you experience side effects, the doctors may not tell you if it’s the drug or another factor unless it is a medical emergency.
- Time Commitment: Trials require frequent clinic visits, blood draws, and daily logging of side effects.